Cargando…

Diagnostic accuracy of a novel point-of-care urine lipoarabinomannan assay for the detection of tuberculosis among adult outpatients in Zambia: a prospective cross-sectional study

BACKGROUND: A novel, rapid, point-of-care urine-based lipoarabinomannan assay (Fujifilm SILVAMP TB LAM (“FujiLAM”)) has previously demonstrated substantially higher sensitivity for tuberculosis (TB) compared with the commercially available Determine TB LAM assay using biobanked specimens. However, F...

Descripción completa

Detalles Bibliográficos
Autores principales: Muyoyeta, Monde, Kerkhoff, Andrew D., Chilukutu, Lophina, Moreau, Emmanuel, Schumacher, Samuel G., Ruhwald, Morten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631000/
https://www.ncbi.nlm.nih.gov/pubmed/33926972
http://dx.doi.org/10.1183/13993003.03999-2020
_version_ 1784607472150904832
author Muyoyeta, Monde
Kerkhoff, Andrew D.
Chilukutu, Lophina
Moreau, Emmanuel
Schumacher, Samuel G.
Ruhwald, Morten
author_facet Muyoyeta, Monde
Kerkhoff, Andrew D.
Chilukutu, Lophina
Moreau, Emmanuel
Schumacher, Samuel G.
Ruhwald, Morten
author_sort Muyoyeta, Monde
collection PubMed
description BACKGROUND: A novel, rapid, point-of-care urine-based lipoarabinomannan assay (Fujifilm SILVAMP TB LAM (“FujiLAM”)) has previously demonstrated substantially higher sensitivity for tuberculosis (TB) compared with the commercially available Determine TB LAM assay using biobanked specimens. However, FujiLAM has not been prospectively evaluated using fresh urine specimens. Therefore, we determined the diagnostic accuracy of FujiLAM among HIV-positive and HIV-negative outpatients with presumptive TB in Zambia. METHODS: Adult (≥18 years old) presumptive TB patients presenting to two outpatient public health facilities in Lusaka were included. All patients submitted sputa samples for smear microscopy, Xpert MTB/RIF and mycobacterial culture, and urine samples for the FujiLAM assay. Microbiologically confirmed TB was defined by the detection of Mycobacterium tuberculosis in sputum using culture; this served as the reference standard to assess the diagnostic accuracy of FujiLAM. RESULTS: 151 adults with paired sputum microbiological tests and urine FujiLAM results were included; 45% were HIV-positive. Overall, 34 out of 151 (23%) patients had culture-confirmed pulmonary TB. The overall sensitivity and specificity of FujiLAM was 77% (95% CI 59–89%) and 92% (95% CI 86–96%), respectively. FujiLAM's sensitivity among HIV-positive patients was 75% (95% CI 43–95%) compared with 75% (95% CI 51–91%) among HIV-negative patients. The sensitivity of FujiLAM in patients with smear-positive, confirmed pulmonary TB was 87% (95% CI 60–98%) compared with 68% (95% CI 43–87%) among patients with smear-negative, confirmed pulmonary TB. CONCLUSIONS: FujiLAM demonstrated high sensitivity for the detection of TB among both HIV-positive and HIV-negative adults, and also demonstrated good specificity despite the lack of systematic extrapulmonary sampling to inform a comprehensive microbiological reference standard.
format Online
Article
Text
id pubmed-8631000
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-86310002021-12-01 Diagnostic accuracy of a novel point-of-care urine lipoarabinomannan assay for the detection of tuberculosis among adult outpatients in Zambia: a prospective cross-sectional study Muyoyeta, Monde Kerkhoff, Andrew D. Chilukutu, Lophina Moreau, Emmanuel Schumacher, Samuel G. Ruhwald, Morten Eur Respir J Original Research Articles BACKGROUND: A novel, rapid, point-of-care urine-based lipoarabinomannan assay (Fujifilm SILVAMP TB LAM (“FujiLAM”)) has previously demonstrated substantially higher sensitivity for tuberculosis (TB) compared with the commercially available Determine TB LAM assay using biobanked specimens. However, FujiLAM has not been prospectively evaluated using fresh urine specimens. Therefore, we determined the diagnostic accuracy of FujiLAM among HIV-positive and HIV-negative outpatients with presumptive TB in Zambia. METHODS: Adult (≥18 years old) presumptive TB patients presenting to two outpatient public health facilities in Lusaka were included. All patients submitted sputa samples for smear microscopy, Xpert MTB/RIF and mycobacterial culture, and urine samples for the FujiLAM assay. Microbiologically confirmed TB was defined by the detection of Mycobacterium tuberculosis in sputum using culture; this served as the reference standard to assess the diagnostic accuracy of FujiLAM. RESULTS: 151 adults with paired sputum microbiological tests and urine FujiLAM results were included; 45% were HIV-positive. Overall, 34 out of 151 (23%) patients had culture-confirmed pulmonary TB. The overall sensitivity and specificity of FujiLAM was 77% (95% CI 59–89%) and 92% (95% CI 86–96%), respectively. FujiLAM's sensitivity among HIV-positive patients was 75% (95% CI 43–95%) compared with 75% (95% CI 51–91%) among HIV-negative patients. The sensitivity of FujiLAM in patients with smear-positive, confirmed pulmonary TB was 87% (95% CI 60–98%) compared with 68% (95% CI 43–87%) among patients with smear-negative, confirmed pulmonary TB. CONCLUSIONS: FujiLAM demonstrated high sensitivity for the detection of TB among both HIV-positive and HIV-negative adults, and also demonstrated good specificity despite the lack of systematic extrapulmonary sampling to inform a comprehensive microbiological reference standard. European Respiratory Society 2021-11-18 /pmc/articles/PMC8631000/ /pubmed/33926972 http://dx.doi.org/10.1183/13993003.03999-2020 Text en Copyright ©The authors 2021. https://creativecommons.org/licenses/by/4.0/This version is distributed under the terms of the Creative Commons Attribution Licence 4.0.
spellingShingle Original Research Articles
Muyoyeta, Monde
Kerkhoff, Andrew D.
Chilukutu, Lophina
Moreau, Emmanuel
Schumacher, Samuel G.
Ruhwald, Morten
Diagnostic accuracy of a novel point-of-care urine lipoarabinomannan assay for the detection of tuberculosis among adult outpatients in Zambia: a prospective cross-sectional study
title Diagnostic accuracy of a novel point-of-care urine lipoarabinomannan assay for the detection of tuberculosis among adult outpatients in Zambia: a prospective cross-sectional study
title_full Diagnostic accuracy of a novel point-of-care urine lipoarabinomannan assay for the detection of tuberculosis among adult outpatients in Zambia: a prospective cross-sectional study
title_fullStr Diagnostic accuracy of a novel point-of-care urine lipoarabinomannan assay for the detection of tuberculosis among adult outpatients in Zambia: a prospective cross-sectional study
title_full_unstemmed Diagnostic accuracy of a novel point-of-care urine lipoarabinomannan assay for the detection of tuberculosis among adult outpatients in Zambia: a prospective cross-sectional study
title_short Diagnostic accuracy of a novel point-of-care urine lipoarabinomannan assay for the detection of tuberculosis among adult outpatients in Zambia: a prospective cross-sectional study
title_sort diagnostic accuracy of a novel point-of-care urine lipoarabinomannan assay for the detection of tuberculosis among adult outpatients in zambia: a prospective cross-sectional study
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631000/
https://www.ncbi.nlm.nih.gov/pubmed/33926972
http://dx.doi.org/10.1183/13993003.03999-2020
work_keys_str_mv AT muyoyetamonde diagnosticaccuracyofanovelpointofcareurinelipoarabinomannanassayforthedetectionoftuberculosisamongadultoutpatientsinzambiaaprospectivecrosssectionalstudy
AT kerkhoffandrewd diagnosticaccuracyofanovelpointofcareurinelipoarabinomannanassayforthedetectionoftuberculosisamongadultoutpatientsinzambiaaprospectivecrosssectionalstudy
AT chilukutulophina diagnosticaccuracyofanovelpointofcareurinelipoarabinomannanassayforthedetectionoftuberculosisamongadultoutpatientsinzambiaaprospectivecrosssectionalstudy
AT moreauemmanuel diagnosticaccuracyofanovelpointofcareurinelipoarabinomannanassayforthedetectionoftuberculosisamongadultoutpatientsinzambiaaprospectivecrosssectionalstudy
AT schumachersamuelg diagnosticaccuracyofanovelpointofcareurinelipoarabinomannanassayforthedetectionoftuberculosisamongadultoutpatientsinzambiaaprospectivecrosssectionalstudy
AT ruhwaldmorten diagnosticaccuracyofanovelpointofcareurinelipoarabinomannanassayforthedetectionoftuberculosisamongadultoutpatientsinzambiaaprospectivecrosssectionalstudy